- Home
- TXMD vs CJET Comparison
TXMD vs CJET Comparison
Compare TXMD & CJET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- CJET
- Stock Information
- Founded
- TXMD 2008
- CJET 2009
- Country
- TXMD United States
- CJET China
- Employees
- TXMD N/A
- CJET N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- CJET Auto Manufacturing
- Sector
- TXMD Health Care
- CJET Consumer Discretionary
- Exchange
- TXMD Nasdaq
- CJET Nasdaq
- Market Cap
- TXMD 12.8M
- CJET 50.7M
- IPO Year
- TXMD N/A
- CJET N/A
- Fundamental
- Price
- TXMD $1.17
- CJET $2.40
- Analyst Decision
- TXMD
- CJET
- Analyst Count
- TXMD 0
- CJET 0
- Target Price
- TXMD N/A
- CJET N/A
- AVG Volume (30 Days)
- TXMD 35.3K
- CJET 8.4K
- Earning Date
- TXMD 08-11-2025
- CJET 07-22-2025
- Dividend Yield
- TXMD N/A
- CJET N/A
- EPS Growth
- TXMD N/A
- CJET N/A
- EPS
- TXMD N/A
- CJET N/A
- Revenue
- TXMD $1,841,000.00
- CJET $6,915,000.00
- Revenue This Year
- TXMD $427.09
- CJET N/A
- Revenue Next Year
- TXMD N/A
- CJET N/A
- P/E Ratio
- TXMD N/A
- CJET N/A
- Revenue Growth
- TXMD 53.55
- CJET N/A
- 52 Week Low
- TXMD $0.70
- CJET $1.09
- 52 Week High
- TXMD $2.44
- CJET $6.64
- Technical
- Relative Strength Index (RSI)
- TXMD 47.76
- CJET 67.63
- Support Level
- TXMD $1.13
- CJET $1.92
- Resistance Level
- TXMD $1.24
- CJET $2.10
- Average True Range (ATR)
- TXMD 0.09
- CJET 0.17
- MACD
- TXMD 0.01
- CJET 0.03
- Stochastic Oscillator
- TXMD 73.12
- CJET 85.61
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About CJET Chijet Motor Company Inc.
Chijet Motor Co Inc is engaged in the development, manufacture, sales, and service of new energy vehicles (NEV), hybrid vehicles and traditional fuel vehicles in China. New energy vehicles refer to plug-in electric vehicles, including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans. The company generates all of its revenue from PRC.